Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy.
Journal: Gastrointestinal endoscopy
Published: January 23, 2018
Sofosbuvir-velpatasvir with ribavirin for 24 weeks in hepatitis C virus patients previously treated with a direct-acting antiviral regimen.
Journal: Hepatology (Baltimore, Md.)
Published: March 07, 2017
Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Hepatitis C Virus Genotype 2, 3, 4, or 6 Infections in an Open-Label, Phase 2 Trial.
Journal: Gastroenterology
Published: May 23, 2016
Sofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus Infection: A Randomized Trial.
Journal: Annals of internal medicine
Published: November 10, 2015
Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1-infected patients without cirrhosis: OPTIMIST-1, a phase 3, randomized study.
Journal: Hepatology (Baltimore, Md.)
Published: September 04, 2015
Longitudinal assessment of colonoscopy quality indicators: a report from the Gastroenterology Practice Management Group.
Journal: Gastrointestinal endoscopy
Published: October 24, 2013
Showing 1-6 of 6
Last Updated: 09/26/2026